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ABSTRACT
cAMP-dependent protein kinase A (PKA) is a ubiquitously expressed
serine/threonine kinase that regulates a variety of cellular functions.
Here, we demonstrate that endothelial PKA activity is essential for
vascular development, specifically regulating the transition from
sprouting to stabilization of nascent vessels. Inhibition of endothelial
PKA by endothelial cell-specific expression of dominant-negative
PKA in mice led to perturbed vascular development, hemorrhage
and embryonic lethality at mid-gestation. During perinatal retinal
angiogenesis, inhibition of PKA resulted in hypersprouting as a result
of increased numbers of tip cells. In zebrafish, cell autonomous PKA
inhibition also increased and sustained endothelial cell motility,
driving cells to become tip cells. Although these effects of PKA
inhibition were highly reminiscent of Notch inhibition effects, our data
demonstrate that PKA and Notch independently regulate tip and stalk
cell formation and behavior.
KEY WORDS: Notch, Angiogenesis, Retina, Signal transduction,
Sprouting, Vascular development
INTRODUCTION
The vascular system in vertebrates forms a vast network of blood
vessels lined by endothelial cells and supporting mural cells. The
architecture and branching pattern of the vasculature is highly
adaptive to meet the needs of tissue growth during development or
changing metabolic demands in physiology as well as during wound
healing and regeneration. Maladaptation of the vasculature is a
hallmark of many disease processes and is likely to result in poor
tissue regeneration in compromised patients. Most of the blood
vessels in the body are formed by angiogenesis, i.e. by outgrowth
from pre-existing blood vessels followed by vascular remodeling.
During remodeling, the nascent vascular network reorganizes
by fusion, widening and pruning of blood vessels to form
functioning vasculature (Eilken and Adams, 2010; Geudens and
Gerhardt, 2011).
Although the main genetic and molecular players orchestrating
vascular development have been identified (Benedito et al., 2012;
Carmeliet and Jain, 2011; Eichmann and Thomas, 2013; Eilken
and Adams, 2010; Geudens and Gerhardt, 2011; Hellström et al.,
2007; Suchting et al., 2007; Wälchli et al., 2015), our
understanding of the signaling program controlling this process
is far from complete. One key pro-angiogenic stimulus is vascular
endothelial growth factor (VEGF), which is produced by hypoxic
tissues to stimulate ingrowth of blood vessels into hypoxic areas.
Stimulation of endothelial cells with VEGF induces formation of
tip cells, highly motile endothelial cells that explore the
environment and migrate up the gradient of VEGF (Gerhardt
et al., 2003; Ruhrberg et al., 2002). Tip cells are followed by stalk
cells, which ensure connection to the pre-existing vasculature and
formation of a new lumenized vessel (Potente et al., 2011). Since
every endothelial cell has the potential to turn into a tip cell under
VEGF stimulation (Jakobsson et al., 2010), a negative regulation is
required to prevent all neighboring cells from becoming tip cells.
This is achieved by Notch-mediated lateral inhibition. The Notch
ligand DLL4, is expressed in tip cells in response to activation of
VEGF receptor 2 (VEGFR2) and activates the Notch1 receptor on
neighboring cells (Hayashi and Kume, 2008; Suchting et al.,
2007). Activation of Notch decreases the levels of VEGFR2 and
VEGFR3 in these cells, thus limiting their ability to respond to
VEGF (Benedito et al., 2012; Hellström et al., 2007; Suchting
et al., 2007). This mechanism drives a dynamic competition for the
tip position.
To inhibit tip cell behavior, Notch signaling cooperates with other
signaling pathways, with BMP signaling being the best-studied
example. BMP9/BMP10-induced activation of ALK1 potentiates
expression of Notch targets in a SMAD-dependent manner to
promote stalk cell behavior (Larrivée et al., 2012). Importantly, our
recent study has demonstrated that neuropilin-1 (NRP1), which is
highly expressed in tip cells, represses ALK5- and ALK1-
dependent SMAD activation. This repression is relieved in stalk
cells, where activation of Notch decreases expression of Nrp1
(Aspalter et al., 2015). The results of this study challenged the
concept of the tip cell being the default state of endothelial cells.
Instead, it appears that tip cell formation and behavior is normally
repressed by constitutive SMAD signaling, which needs to be
released for tip cell activation. Moreover, in addition to the correct
signaling repertoire, the tip cell requires appropriate metabolic
regulation. Endothelial cell ATP production relies heavily on
glycolysis and deficiency of the glycolytic activator PFKFB3
decreases sprouting and reduces the number of tip cells, even when
Notch is inactive (De Bock et al., 2013).
Despite the identification of these critical regulators, the
intracellular integration of multiple extracellular signaling inputs
in endothelial cells in sprouting angiogenesis remains unclear. One
of the major mechanisms to translate such extracellular inputs into aReceived 4 January 2016; Accepted 8 August 2016
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cellular response is protein and lipid phosphorylation. However,
specific roles for regulation of phosphorylation during angiogenesis
have been assigned to only a few kinases and phosphatases (Deng
et al., 2013; Nakayama et al., 2013; Serra et al., 2015; Yoshioka
et al., 2012).
Cyclic AMP (cAMP)-dependent protein kinase A (PKA) is a
ubiquitously expressed protein kinase with a large number of
potential targets (Shabb, 2001; Skroblin et al., 2010; Taylor et al.,
2012). The main regulator of PKA activity is cAMP produced by
adenylyl cyclases, which are both positively and negatively
regulated by G protein-coupled receptors (GPCRs). Since GPCRs
constitute the largest receptor family, with many of its members
directly or indirectly regulating cAMP levels, PKA represents a
signaling hub for a large variety of hormones, neurotransmitters and
cytokines and thus regulates a plethora of physiological processes
(Taskén and Aandahl, 2004). PKA has been shown to regulate
different aspects of endothelial cell physiology (Aslam et al., 2010;
Collins et al., 2014; Goldfinger et al., 2008; Lu et al., 2011) and to
inhibit angiogenesis when activated pharmacologically (Bakre
et al., 2002; Jin et al., 2010). However, a demonstration of
whether endothelial PKA is required during vascular development
in vivo has been missing.
Here, we describe a previously unidentified role for PKA in the
regulation of angiogenesis and vascular development. Inhibition of
endothelial PKA in mice results in embryonic vascular defects,
hemorrhage and lethality at midgestation. Analysis of angiogenesis
in mouse retina and zebrafish revealed that inhibition of endothelial
PKA induces excessive formation of tip cells, increased cell
migration and hypersprouting in a Notch-independent manner.
RESULTS
Endothelial PKA activity is required for embryonic vascular
development
To study the role of PKA in vascular development we inhibited
PKA in endothelial cells using knock-in mice carrying a single
floxed dominant-negative Prkar1a allele (dnPKA; Fig. 1A)
knocked into the genomic Prkar1a locus allowing tissue-specific
inhibition of PKA (Willis et al., 2011). The regulatory PRKAR1A
subunit of PKA is an endogenous inhibitor of PKA, which binds
and keeps the catalytic subunits inactive under low cAMP levels
(Kumon et al., 1970; Tao et al., 1970). With increasing cAMP
levels, cAMP binds to PRKAR1A, induces its conformational
change and releases the catalytic subunit (PRKAC; Fig. 1B), which
is now active. A G324D point mutation introduced into PRKAR1A
Fig. 1. Endothelial PKA is required for embryonic
vascular development. (A) To inhibit PKA activity, a
dominant-negative approach was used. In this approach,
one of the alleles of the regulatory PKA subunit Prkar1a
(a), was modified by introducing a G324D point mutation
into exon 11 and inserting a floxed Neo cassette between
exons 10 and 11. In the absence of Cre recombinase, the
transgenic allele remains silent and the wild-type copy of
Prkar1a is expressed (b). In the presence of Cre
recombinase, the Neo cassette is excised and dominant-
negative PKA (dnPKA) is expressed resulting in inhibition
of PKA (c). (B) Schematic illustration of cAMP-dependent
activation of PKA (a) and its inhibition by dnPKA
transgene (b). PKA is a heterotetramer consisting of two
regulatory (blue) and two catalytic (green) subunits. The
regulatory subunits bind the catalytic ones and prevent
their activity. Binding of cAMP to the regulatory subunits
relieves their inhibitory action and leads to dissociation of
the active catalytic subunit. dnPKA (red) has much lower
binding affinity to cAMP and keeps the catalytic subunits
bound and inactive, even at increased cAMP levels. (C)
Fraction of viable embryos from the cross of Prkar1aTg/+
and Tie2-CreTg/− mice. Viability was assessed by the
presence of a heartbeat during preparation of the
embryos. (D) Endomucin staining of E10.5 wild-type and
dnPKAEC littermates. (E,F) Appearance of the yolk sac
(E) and embryo proper (F) of wild-type (left) and
dnPKAEC littermates (right) at E11.5. (H) E11.5 yolk sac
vasculature of wild-type (left) and dnPKAEC littermates
(right) was visualized by expression of mT/mG
transgene.
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renders it insensitive to cAMP and thereby turns it into a constitutive
inhibitor of PKA. In the absence of Cre recombinase expression, the
floxed allele is silent, thus resembling a PRKARA1 knockout allele.
Since PRKAR1A is essential for early embryonic development and
Prkar1a−/− mice show delay in development as early as embryonic
day (E)7.5 and are resorbed by E10.5 (Amieux et al., 2002), only
hemizygote floxed dominant-negative Prkar1a (Prkar1aTg/+) mice
are viable and were used in this study (see Fig. 1A,B for details on
genetic approach and inhibition of PKA by dnPKA). Consequently,
PKA in Prkar1aTg/+ cells is not completely inhibited, but only by
∼50% (Willis et al., 2011). In good agreement, we found that
cAMP-induced phosphorylation of the PKA target CREB in
dnPKA-expressing endothelial cells was reduced to 58±21% of
levels in wild-type cells (data not shown).
To achieve endothelial-specific inhibition of PKA, Prkar1aTg/+
mice were crossed with mice expressing Cre recombinase under the
control of an endothelial cell-specific promoter (Tie2-Cre)
(Kisanuki et al., 2001). Prkar1aTg/+;Tie2-Cre (hereafter referred
to as dnPKAEC) embryos were present at a Mendelian ratio between
E8.5 and E10.5; however, no dnPKAEC embryo could be recovered
at E12.5 (Fig. 1C). To investigate whether inhibition of endothelial
PKA results in perturbed vasculogenesis or early angiogenesis,
E10.5 embryos were stained for the endothelial marker endomucin.
Although dnPKAEC embryos were smaller than their wild-type
littermates, endomucin staining depicted a vasculaturewithout gross
abnormalities (Fig. 1D), suggesting that vasculogenesis and early
angiogenesis proceed adequately in dnPKAEC embryos.
By E11.5, only a minor fraction of dnPKAEC embryos were alive
and displaying a heartbeat (Fig. 1C). All showed large hemorrhages
in the abdominal area and no visible signs of blood in the yolk
sac (Fig. 1E,F). Visualization of the yolk sac vessels in dnPKAEC
embryos carrying the mT/mG Cre-recombination marker
demonstrated that the mutants had a reduced vascular plexus
density and vessels of smaller caliber, with many of them very thin
and probably undergoing regression (Fig. 1H).
Inhibition of endothelial PKA results in vascular
hypersprouting
To separate the primary effects of PKA inhibition on vascular
development from secondary defects accompanying defective
vascularization of the embryo, we studied PKA inhibition in
postnatal retinal angiogenesis. An essential advantage of this model
is that retinal angiogenesis takes place after a functional circulatory
system has been formed. While perturbation of embryonic
angiogenesis will inevitably result in malfunction of the
developing cardiovascular system and may induce severe
secondary defects due to hypoxia or malnutrition, the systemic
postnatal circulation is much less affected by inhibition of
angiogenesis. Prkar1aTg/+ mice were crossed with mice
expressing tamoxifen-inducible Cre recombinase under control of
endothelial-specific Cdh5 promoter (Cdh5-CreERT2; Wang et al.,
2010). Recombination was induced by daily tamoxifen injection at
postnatal day (P)1 to P3 and angiogenesis was analyzed in retinas
from Prkar1aTg/+;Cdh5-CreERT (hereafter dnPKAiEC) and Cdh5-
CreERT (wt) littermates.
Analysis of the retinal vasculature at P4 showed that inhibition of
endothelial PKA resulted in formation of a hyperdense plexus front
(Fig. 2A and Fig. S1A) with significantly increased endothelial cell
proliferation, vessel area and number of sprouts (Fig. 2B). Therewas
no difference in the size or weight of mutant and wild-type pups,
indicating that the observed effects were not due to general
developmental defects. Vascular progression assessed by radial
expansion of the plexus was decreased in a fraction of mutant retinas
(Fig. S1A); however, no significant difference over the whole
population of analyzed pups was observed (Fig. 2B). The increased
vascular density persisted at P7 (Fig. S1B,C), whereas there was no
significant difference in the number of sprouts at this time point.
Similar phenotypic changes were observed when expression of
dnPKA was induced using a second endothelial-specific Cre line,
Pdgfb-iCreERT (Claxton et al., 2008) (Fig. 2D). While the Cdh5-
CreERT studies were performed on a mixed N/FVB×C57 (with at
least 75% N/FVB) background, the Pdgfb-iCreERT2 studies were
in the C57/Bl6 background, demonstrating that the effects of
endothelial dnPKA on angiogenesis were independent of the Cre
line or genetic background.
After the initial formation of a relatively uniform immature
plexus, the vascular network undergoes dramatic remodeling to
form the hierarchically branched mature plexus (Fruttiger, 2007).
Artery and vein formation occurred in dnPKAiEC mice, and a
hierarchical branching pattern emerged, albeit with altered
complexity, suggesting that PKA inhibition does not prevent
vascular remodeling (Fig. 2A). However, we observed an
increased number of arteriovenous crossovers in dnPKAiEC retinas
(Fig. S1B,D). Interestingly, when comparing wild-type and
dnPKAiEC retinas in 1-month-old mice, there were no obvious
differences in the vascular architecture, except for the arteriovenous
crossovers (Fig. S2). This indicates that inhibition of endothelial
PKA specifically impairs retinal vascular development at the
sprouting stage and that remodeling can ultimately correct many but
not all patterning defects.
Inhibition of endothelial PKA increases tip cell numbers
The hyperdense frontal plexus and increased number of sprouts
indicated an increased number of tip cells. To assess the number of
tip cells, we stained retinas with the tip cell-specific marker ESM1
(del Toro et al., 2010; Xu et al., 2014). As expected, only few single
cells at the vascular front were stained in wild-type retinas (Fig. 2C,
top panels) confirming that ESM1 is a reliable tip cell marker. In
contrast, in dnPKAiEC mice, ESM1 staining extended far into the
vascular plexus (Fig. 2C, bottom panels). Combined, these data
indicate that inhibition of PKA leads to hypersprouting as a result of
an increased number of tip cells.
Next, we sought to understand whether the increased number of
tip cells reflects an impaired regulation of angiogenesis by external
factors or intrinsic properties of endothelial cells under PKA
inhibition. Both pericytes and basement membrane have been
shown to restrain vascular sprouting (Gaengel et al., 2009; Stenzel
et al., 2011) and thus, defects in recruitment of pericytes or
formation of basement membrane could be a reason for extensive
sprouting in dnPKAiEC mice. To study whether defective interaction
with mural cells or deposition of extracellular matrix may be the
reason for the observed phenotype, retinas were stained for NG2, a
marker of pericytes, and collagen IV, a component of the vascular
basement membrane (Fig. S1A). However, no defects in coverage
by pericytes or basement membrane could be observed in
dnPKAiEC retinas, indicating that neither the recruitment of
pericytes nor the ability of endothelial cells to deposit basement
membrane proteins is affected by PKA inhibition.
To study whether inhibition of PKA increases the probability for
an endothelial cell to gain the tip cell position cell-autonomously,
we performed mosaic studies in the zebrafish model. Intersegmental
vessels (ISVs) in zebrafish are formed by sprouting from the dorsal
aorta. Endothelial tip/stalk cell selection, migration and proliferation
establish bilateral ISVs, which upon reaching the dorsal aspect of
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the neural tube, form a pair of dorsal longitudinal anastomotic
vessels (DLAVs). To inhibit PKA in a cell-specific manner, we
injected Tg( fli1a:eGFP)y1 (Lawson andWeinstein, 2002) zebrafish
eggs at the one or two cell stage with a vector expressing a specific
PKA inhibitor peptide (PKI) (Murray, 2008), fused to mCherry
fluorescent protein and placed under the control of the endothelial
cell-specific fli1 enhancer/promoter (fli1ep; Villefranc et al., 2007).
Determining the location of mCherry-positive cells in mosaic ISVs
(consisting of both PKI-mCherry-positive and -negative cells), we
found that PKI-expressing cells were significantly over-represented
at the leading (tip cell) position compared with the stalk position
(Fig. 3A). In control experiments, using a construct expressing red
fluorescent protein (RFP) under the same promoter, RFP-positive
control cells were equally frequent at tip and stalk position (ratio
close to 1). These results suggest that PKI inhibition conveys a
capacity to endothelial cells to attain the tip position. In addition, we
observed that PKI-expressing cells have more filopodia than cells
expressing control fluorescent protein (Fig. 3B).
In order to gain insights into the mechanism, we assessed the
dynamic behavior of PKI-expressing cells. For better visualization
of the endothelial cell membrane, we used the Tg(Kdr-l:ras-
Cherry)s916 line, which expresses a membrane-bound fluorescent
protein (Hogan et al., 2009). To inhibit PKA, we used a PKI-GFP
fusion protein. We followed the development of blood vessels in
Fig. 2. Inhibition of endothelial PKA leads
to retinal hypersprouting and increased
tip cell number. (A) Retinas from wild-type
(Cdh5-CreERT2) and dnPKAiEC littermates
were isolated at indicated time points and
the vasculature was visualized using
isolectin B4-Alexa Fluor 568.
(B) Quantification of pup weight, retinal
vascular area, incorporation of EdU, number
of sprouts and vascular progression in wild-
type and dnPKAiEC littermates at P4. Shown
aremeans±s.d. of at least eight mice from at
least three different litters. Data were
analyzed using a Student’s t-test; *P<0.05,
**P<0.01. (C) Retinas from wild-type and
dnPKAiEC littermates were isolated at P4
and stained with isolectin B4 for vasculature
(green on overlay image) and anti-ESM-1
antibody for tip cells (red on the overlay
image). (D) Retinas from PDGFB-iCre and
PDGFB-iCre:dnPKA littermates were
isolated at P4 and vasculature stained with
isolectin B4.
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mosaic PKI-GFP-expressing fish embryos from 29 hours post
fertilization (hpf ) until 42 hpf (Fig. 3C and Movies 1 and 2).
Compared with control cells, PKI-GFP-expressing cells formed
more abundant and highly explorative filopodia (Fig. 3C and
Movie 1). While control cells ceased filopodia formation after
anastomosing and forming DLAVs, PKI-GFP-positive cells
retained filopodial activity and kept migrating, even after
anastomosis (Movie 1). This increased motility of endothelial
cells correlated with an apparent instability of blood vessels, since
the lumen of PKI-expressing ISVs often collapsed after perfusion
had started (Movie 2). In contrast, ISVs in controls rarely display
this behavior as perfusion stabilizes nascent lumen and vessel
connections through shear-mediated mechanisms (Movie 2).
PKA inhibition or activation do not affect Notch signaling
Given that inhibition of endothelial PKA in dnPKAiEC mice leads to
a hypersprouting phenotype that is similar to the one observed upon
loss of DLL4 or inhibition of Notch signaling (Hellström et al.,
2007; Suchting et al., 2007), we investigated whether inhibition of
endothelial PKA affects DLL4/Notch signaling. First, we analyzed
DLL4 distribution in P4 retinas. Similar to ESM1 staining (Fig. 2C),
DLL4 distribution extended further into the plexus in dnPKAiEC
mice (Fig. 4A) and was not visibly reduced, suggesting that the
observed hypersprouting is not due to loss of DLL4 expression. In
wild-type and dnPKAiEC retinas, DLL4 staining was virtually
absent in the veins while present in the arteries and at the sprouting
front, indicating that PKA inhibition neither reduces DLL4 nor
induces generalized ectopic expression of DLL4. Instead, the wider
zone of DLL4 expression at the sprouting front, similar to ESM1, is
likely to be a consequence of the increased number of tip cells.
To further investigate whether Notch signaling is affected by
PKA inhibition, we analyzed the expression of genes regulated by
Notch in endothelial cells isolated from retinas of wild-type and
dnPKAiEC mice. QPCR analysis demonstrated that out of all Notch
targets studied (Dll4, Hes1, Hes2, Hey1, Vegfr1, Vegfr2, Esm1 and
Nrp1), only Esm1 showed an increase in expression (about 2-fold)
in dnPKAiEC mice compared with the wild type (Fig. 4B). Since
most of these markers were not affected, we concluded that
inhibition of PKA had only a limited, if any, effect on Notch
signaling.We speculate that the increase of Esm1 expression reflects
the increased number of tip cells rather than a direct induction due to
inhibition of Notch. Indeed, it has been demonstrated that Esm1
expression is increased 11-fold under inhibition of Notch (del Toro
et al., 2010), whereas we find only a 2-fold increase under inhibition
of PKA. We also tested expression of another gene, Cxcl2, which
has been shown to be upregulated more than 13-fold under
inhibition of Notch (del Toro et al., 2010). Again, we detected only a
modest 1.4-fold increase of mRNA in endothelial cells from
dnPKAiEC retinas (data not shown). Altogether, these data indicate
that PKA does not operate upstream of Notch signaling in regulating
endothelial tip/stalk specification.
An alternative explanation for hypersprouting in dnPKAiEC mice
is that Notch acts upstream of PKA, with PKA mediating the anti-
angiogenic effect of Notch. To test this hypothesis, we transfected
HUVECs with a luciferase-based reporter for PKA (CRE-Luc,
firefly luciferase under control of the cAMP response element) or
Notch [TP1-Luc, firefly luciferase under the control of the Epstein
Barr Virus terminal protein 1 (TP1) gene, which contains two Rbp-
Jκ binding sites (Grossman et al., 1994; Henkel et al., 1994)]. To
activate Notch, cells were seeded on plates coated with DLL4; for
PKA activation, cells were treated with a membrane-permeable
cAMP analog, CPT-cAMP. DLL4 strongly increased the signal of
Fig. 3. Inhibition of endothelial PKA increases the motility of endothelial
cells and their probability to become a tip cell. (A) Tg( fli1a:eGFP)y1
zebrafish embryos were injected with a plasmid encoding RFP (as control) or
PKI-mCherry fusion protein (left). Localization of the cells expressing
red fluorescent protein was determined at 29 hpf. Mosaic ISVs (containing
both transfected and untransfected cells) were used to identify whether
transfected cells were in a tip or stalk cell position. RFP and PKI-mCherry
signals are in black and white on the left panel and in red on the overlay
image (middle); GFP signal is green on the overlay image. Ratio of tip-to-stalk
cells for RFP-expressing (control) and PKI-mCherry-expressing (PKI)
cells (right). For RFP and PKI, 15 and 26 embryos were analyzed,
respectively. The number of analyzed cells is indicated on the figure
(Chi-square test: P<0.05). (B) Filopodia in endothelial cells expressing control
fluorescent protein or PKI-mCherry fusion were analyzed in fish
embryos. Shown are representative images of cells expressing control
fluorescent protein (RFP; left) or PKI-mCherry (PKI; middle) and
quantification of filopodia number per cell (right). For RFP and PKI, 20 and 29
embryos were analyzed, respectively. The number of analyzed cells is
indicated on the figure. Boxes encompass values between the 25th and 75th
percentiles, centered lines represent median, mean is indicated by +, whiskers
and outliers are calculated using the Tukey method (*P<0.05).
(C) Tg(Kdrl:Ras-mCherry)s916 embryos were injected with plasmid expressing
PKI-GFP fusion under the control of endothelial fli1ep promoter and
vascular development was monitored from 29 to 42 hpf. Membrane-bound
mCherry fluorescent protein (black in left panel and red on the right)
depicts higher mobility and excessive filopodia formation in
PKI-GFP-expressing cells (green) compared with the wild-type GFP-negative
cells. The approximate area imaged is depicted on the insert showing the
zebrafish embryo.
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the TP1-Luc reporter, but cAMP had no significant effect on the
Notch reporter, either in the presence or in the absence of DLL4
(Fig. 4C). Furthermore, DLL4 did not affect the activity of the PKA
reporter and did not enhance its activation induced by the cAMP
analog (Fig. 4C), suggesting that the cAMP/PKA-dependent
pathway andNotch signaling are not intertwined in endothelial cells.
Inhibition of PKA and Notch has an additive effect on retinal
angiogenesis
To directly test in vivo whether PKA inhibition exerts its
effects on retinal angiogenesis in parallel to and independent
of Notch signaling, we inhibited both PKA and Notch and
analyzed retinal angiogenesis. Notch signaling was inhibited by
DAPT {N-[(3,5-Difluorophenyl)acetyl]-L-alanyl-2-phenylglycine-
1,1-dimethylethyl ester} an inhibitor of γ-secretase, which is
required for Notch processing and activation. Similar to PKA
inhibition and as published before (Benedito et al., 2012; Hellström
et al., 2007; Suchting et al., 2007), DAPT treatment led to increased
sprouting at the vascular front and increased vessel density
(Fig. 4D). Interestingly, inhibition of Notch in dnPKAiEC mice
resulted in even stronger hypersprouting and higher number of tip
cells than in DAPT-treated wild-type mice or untreated dnPKAiEC
mice (Fig. 4D). Combined, these data demonstrate that although
inhibition of PKA and Notch has very similar phenotypic effects on
retinal angiogenesis, mechanistically, the two pathways operate
largely independently.
DISCUSSION
During the past decade, several signaling pathways regulating
angiogenesis have been discovered. As both deficient and excessive
angiogenesis may be deleterious, a tight balance between positive
and negative regulators is required to ensure that the formation of
functional vesselsmeeting the needs of the organism. Here, we show
that the signaling hub PKA has crucial anti-angiogenic activity
during vascular development. Inhibition of endothelial PKA inmice
caused severe vascular abnormalities, vascular leakage, hemorrhage
and ultimately, embryonic lethality during development. Postnatal
inhibition of PKA in the retinal angiogenesis model revealed
profound hypersprouting and increased tip cell numbers.
It has previously been demonstrated that pharmacological
activation of PKA in chick chorioallantoic membrane or zebrafish
embryo reduced angiogenesis (Bakre et al., 2002; Jin et al., 2010).
However, whether PKA is activated endogenously as a part of a
signaling network regulating angiogenesis has remained
unanswered. Earlier studies that applied the PKA inhibitor H89 to
zebrafish embryos noted the formation of ectopic sprouts (Jin et al.,
2010). However, considering the global inhibition of PKA by the
inhibitor and its potential to inhibit multiple protein kinases
(Bain et al., 2007), it has been unclear to what extent endothelial
PKA was responsible for the observed effects. Using genetic
inhibition of PKA in endothelial cells in mouse, we demonstrate that
endothelial PKA is cell-autonomously essential for normal vascular
development.
Fig. 4. PKA and Notch independently regulate
endothelial cell behavior during angiogenesis.
(A) Retinas from wild-type (Cdh5-CreERT2) and
dnPKAiEC littermates were isolated at P4 and stained for
DLL4. For both wt and dnPKAiEC, 12 pups from three
different litters were analyzed and representative
images are shown. (B) Retinal endothelial cells were
isolated at P6 and expression levels of the indicated
genes were analyzed by qPCR. Shown are fold
differences of expression in dnPKAiEC over wt cells.
Data are means±s.d. of four independent experiments.
(C) HUVECs were transfected with the luciferase
reporter for PKA (CRE-Luc) or Notch (TP1-Luc) and
seeded onto dishes coated with DLL4 (DLL4+) or BSA
(DLL4−). To activate PKA, 50 µM CPT-cAMP (a cell-
permeable cAMP analog) was added where indicated.
Data were normalized to the activity in the presence of
DLL4 (for TP1-Luc) and cAMP (for CRE-Luc). Shown
are means±s.d. for three independent experiments,
each performed in triplicate. (D) Wild-type (Cdh5-
CreERT2) and dnPKAiEC littermates were injected with
tamoxifen at P1-P3 andwith 100 mg/kgDAPTor vehicle
only at P2 and P3, retinas were dissected at P4 and the
vasculature was visualized using isolectin B4-Alexa
Fluor 568. Four litters were analyzed and representative
images are shown; number of pups analyzed for each
condition is indicated on the figure.
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In vivo studies in mouse and zebrafish allowed us to unravel a
specific role for PKA during vascular development. While
diminished PKA activity does not prevent vasculogenesis and
early angiogenesis, it leads to excessive formation of tip cells and
hypersprouting.
Since the effects of PKA inhibition are reminiscent of the effects
of Notch inhibition, one possible explanation would be that both
pathways converge in endothelial cells. PKA has been shown to
activate Notch signaling in monocytes (Larabee et al., 2013) and to
increase the level of the Notch ligand Jagged1 in osteoblasts
(Weber et al., 2006). Moreover, both PKA and Notch
synergistically promote self-renewal of glioma-initiating cells
(Wang et al., 2014). However, the results of our study do not
support an interaction between PKA and Notch in endothelial cells.
First, activation of PKA in HUVECs did not activate Notch; neither
did activation of Notch affect PKA activity. Second, in endothelial
cells isolated from dnPKAiEC retinas, Notch signaling seems to
operate normally, since the expression of Notch targets (Hes1,
Hey1, Hey2, Vegfr1, Vegfr2, Nrp1 and Cxcl2) was similar to that in
endothelial cells from wild-type retinas. The only exception was
Esm1, which was significantly increased in the total population of
isolated retinal dnPKAiEC-expressing endothelial cells. Esm1 has
previously been shown to be increased in retinal endothelial cells
under Notch inhibition (del Toro et al., 2010). However, while
Esm1 was increased ∼2-fold in cells from dnPKAiEC retinas, it
increased by more than 11-fold under inhibition of Notch (del Toro
et al., 2010). Also, by immunostaining, we found that DLL4 ligand
expression levels and pattern were similar to wild-type retinas,
although with a wider distribution in the hypersprouting plexus at
the front, corresponding to the region of increased tip cell
formation. This would suggest that Notch itself is not affected by
PKA inhibition. Instead, we hypothesize that the quantitative
increase in Esm1 mRNA is related to the increased number of tip
cells in dnPKAiEC retinas. Indeed, immunostaining identified that
the number of ESM1-expressing cells is much higher in dnPKAiEC
retinas compared with wild-type retinas. Taken together, these data
led us to the conclusion that the role of endothelial PKA during
sprouting angiogenesis is to restrain formation of tip cells. Future
studies will need to clarify whether PKA is (transiently) activated
in tip cells and facilitates their transition to stalk cells, or whether it
is selectively active in stalk cells and prevents them from becoming
tip cells. Furthermore, the molecular mechanism behind PKA
regulation of tip/stalk activity will need to be elucidated. One
possibility would be that the increase in ESM1 observed under
PKA inhibition is directly causing increased hypersprouting.
ESM1 plays an active role during retinal angiogenesis since its
deletion leads to a delay in vascular outgrowth and a decreased
number of endothelial cell filopodia during retinal angiogenesis
(Rocha et al., 2014). Therefore one might speculate that the
elevated ESM1 in dnPKAiEC mechanistically drives
hypersprouting.
Another important question will be what is the upstream
activator of endothelial PKA during vascular development.
Usually, PKA is activated in response to stimulation of GPCRs
and consecutive elevation of cAMP. Several GPCRs and their
ligands have been shown to regulate cAMP level or PKA activity
in endothelial cells (Aslam et al., 2012; Bakre et al., 2002;
Dormond et al., 2002), some of which have been proposed to
activate PKA during vascular development (Jin et al., 2010).
However, it remains unclear as to which GPCRs indeed regulate
endothelial PKA during vascular development. Interestingly, in
endothelial cells, PKA can be also activated by shear stress (Dixit
et al., 2005; Funk et al., 2010), tension (Collins et al., 2014) or
VEGF (Lu et al., 2011). PKA mediates alignment of endothelial
cells in response to flow (Goldfinger et al., 2008), adjustment of
endothelial cell stiffness in response to pulsatile force (Collins
et al., 2014) and VEGF-induced activation of nitric oxide synthase
(Lu et al., 2011). Importantly, in vivo data suggest that activation of
PKA in response to flow may be mediated through a well-known
GPCR axis. Siekmann and colleagues have demonstrated that
vessel perfusion in zebrafish and the subsequent decrease in
filopodia number is accompanied by decreased expression of
CXCR4 in endothelial cells (Bussmann et al., 2011). Since
CXCR4 is a GPCR that activates Gαi protein (Klein et al., 2001)
and thus inhibits adenylyl cyclase-mediated cAMP production,
downregulation of CXCR4 may result in activation of PKA
endothelial cells in response to flow. One may speculate that such
activation of PKA might function to switch off exploratory
behavior of endothelial cells after perfusion has been established.
While the upstream regulator of endothelial PKA remains to be
identified, our data demonstrating sustained exploratory behavior
of endothelial cells under PKA inhibition are a strong indication
that PKA is indeed required for a flow-mediated switch in
endothelial cell behavior.
In summary, our data demonstrate that PKA is an essential
regulator of angiogenesis and vascular development, which controls
tip/stalk cell behavior independent of Notch signaling. It remains to
be revealed whether PKA and Notch operate simultaneously to
reinforce the anti-angiogenic effect of each other or whether they
regulate different cellular events during tip cell specification and tip-
to-stalk cell transition.
MATERIALS AND METHODS
Animal procedures
All experimental animal procedures were approved by the Institutional
Animal Care and Research Advisory Committee of the University of Leuven
and performed according to European guidelines. The following mouse
strains were used: Prkar1atm2Gsm (Willis et al., 2011), Tg(Cdh5-cre/
ERT2)1Rha (Wang et al., 2010), Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J
(Muzumdar et al., 2007), Tg(Pdgfb-icre/ERT2)1Frut (Claxton et al., 2008)
and Tg(Tek-cre)1Ywa/J (Kisanuki et al., 2001). All animals used in the
experiments were mixed N/FVB×C57/Bl6 mice with at least 75% N/FVB.
All comparisons were done between littermates only. For staging the
embryos, the morning when the vaginal plug was detected was considered to
be E0.5. For retinal angiogenesis assay, 50 µg tamoxifen per pup was
applied by intraperitoneal injection daily on P1-P3 (Pitulescu et al., 2010).
Eyes were harvested at the indicated time point, fixed in 4%
paraformaldehyde at room temperature for 30 min and retinas were
dissected.
Retinal angiogenesis assay
Isolation and staining of the retinas was performed according to a published
protocol (Pitulescu et al., 2010). The vasculature was visualized with
isolectin B4 coupled to Alexa Fluor 568. The following primary antibodies
were used for staining: ESM1 (R&D Systems, AF1999; 1:100), NG2
(Millipore, AB5320; 1:100), collagen IV (AbD Serotec, 2150-1470; 1:200).
Alexa Fluor 647-coupled secondary antibodies (dilution 1:500) were used
(Thermo Fisher Scientific). After mounting, images were recorded using a
Leica SP8 system.
Live imaging in zebrafish
Tg( fli1a:eGFP)y1 (Lawson and Weinstein, 2002) and Tg(Kdr-l:ras-
Cherry)s916 (Hogan et al., 2009) zebrafish lines were maintained
according to EU regulations on laboratory animals. Embryos were
injected at the one- to two-cell stage with 50 pg plasmid and 50 pg Tol2
transposase RNA. Capped mRNAs were transcribed with the SP6
mMESSAGE mMACHINE Kit (Ambion). For real-time imaging,
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embryos were mounted in 0.8% low-melting agarose containing 0.01%
Tricaine (Sigma) and bathed in Danieau’s buffer and imaged every 25 min
on a confocal Leica SP8 microscope at 28°C.
Retinal endothelial cell isolation
Mouse retinal endothelial cells were isolated according to a published
protocol (del Toro et al., 2010). Briefly, pups were genotyped and retinas
of the same genotype were pooled together (4-10 retinas depending on
the size of the litter and the mutant to wild type proportion) for endothelial
cell isolation. Retinas were incubated in 5 ml Dulbecco’s modified
Eagle’s medium (4.5 g/l glucose with L-glutamine) containing 50 mg/ml
collagenase (Invitrogen, 17018-029) in 15 ml tube for 10-15 min at
37°C. Another 5 ml DMEM containing 10% FBS, 50 U/ml penicillin and
50 µg/ml streptomycin was added to the incubation tube and the cells were
passed through 40 µm Nylon cell strainer (BD Falcon), centrifuged at 180 g
for 5 min, resuspended in cold washing buffer (PBS supplemented with
0.1% BSA and 0.5 mM EDTA) and rotated with Dynabeads sheep anti-rat
IgG (Invitrogen, 11035) pre-incubated with purified rat anti-mouse CD31
(BD Pharmingen, 553370) for 20 min at 4°C. The beads were separated
and washed with cold washing buffer using a magnetic particle
concentrator (Dynal MPC-S; Invitrogen) and stored at −80°C. The cells
not bound to the beads were saved as the non-endothelial cell fraction and
used as reference to validate enrichment of vascular markers in the
endothelial cell preparation.
Quantitative PCR
Total RNAwas purified from retinal endothelial cells using Qiagen RNeasy
Mini kit following the manufacturer’s protocol. Samples were quality
controlled using a Nanodrop 2000 (Thermo Fisher Scientific). Total RNA
(300 ng) was reverse transcribed into cDNA using a High Capacity RNA-to-
cDNAKit (Applied Biosystems). Quantitative PCR (QPCR) was performed
using Fast SYBR Green PCR Master Mix (Applied Biosystems) in a 7500
fast Real-Time PCR system (Applied Biosystems) with specific primers as
listed in supplementary Materials and Methods. For each condition, four
independent experiments were analyzed and fold changes were calculated
using the comparative −ΔΔCT method using Gapdh as a housekeeping
gene. Then, fold changes were normalized to Pecam1 level to account for
possible differences in the number of endothelial cells.
Luciferase assay
Human umbilical vein endothelial cells (HUVECs) were purchased from
Promocell (Heidelberg, Germany). To detect PKA and Notch activity in
endothelial cells, 70% confluent HUVECs growing on a 10 cm dish were
transfected with a plasmid encoding firefly luciferase reporter either using
CRE-Luc (Promega) or TP1-Luc. Transfection was performed using
X-tremeGENE HP DNA transfection reagent (Roche). Cells were split
6 h after transfection and plated on 24-well dishes coated with 1 µg/ml BSA
in 0.1% gelatin (control) or 1 µg human recombinant Dll4 (R&D
Systems) in 0.1% gelatin (DLL4 treatment). Cells were treated with the
cell-permeable cAMP analog CPT-cAMP (BIOLOG Life Science Institute)
18 h after plating. After 6 h, cells were lysed and luciferase activity was
measured.
Statistical analysis
Statistical analyses were performed using Prism 6 (GraphPad). The
Student’s t-test was used to compare two different groups (Fig. 2B and
Fig. 3B, Fig. S1C) and one-way ANOVA to compare more than two
experimental groups (Fig. 4B). One-tailed Fisher’s test was used to compare
tip/stalk cells ratio for Fig. 3A.
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promotes integrin alpha Vbeta 3-dependent endothelial cell adhesion, rac-
activation, and spreading through cAMP/PKA-dependent signaling. J. Biol. Chem.
277, 45838-45846.
Eichmann, A. and Thomas, J.-L. (2013). Molecular parallels between neural and
vascular development. Cold Spring Harb. Perspect. Med. 3, a006551.
3589
RESEARCH ARTICLE Development (2016) 143, 3582-3590 doi:10.1242/dev.134767
D
E
V
E
LO
P
M
E
N
T
Eilken, H. M. and Adams, R. H. (2010). Dynamics of endothelial cell behavior in
sprouting angiogenesis. Curr. Opin. Cell Biol. 22, 617-625.
Fruttiger, M. (2007). Development of the retinal vasculature. Angiogenesis 10,
77-88.
Funk, S. D., Yurdagul, A., Green, J. M., Jhaveri, K. A., Schwartz, M. A. and Orr,
A. W. (2010). Matrix-specific protein kinase A signaling regulates p21-activated
kinase activation by flow in endothelial cells. Circ. Res. 106, 1394-1403.
Gaengel, K., Genove, G., Armulik, A. and Betsholtz, C. (2009). Endothelial-mural
cell signaling in vascular development and angiogenesis. Arterioscler. Thromb.
Vasc. Biol. 29, 630-638.
Gerhardt, H., Golding, M., Fruttiger, M., Ruhrberg, C., Lundkvist, A.,
Abramsson, A., Jeltsch, M., Mitchell, C., Alitalo, K., Shima, D. et al. (2003).
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell
Biol. 161, 1163-1177.
Geudens, I. and Gerhardt, H. (2011). Coordinating cell behaviour during blood
vessel formation. Development 138, 4569-4583.
Goldfinger, L. E., Tzima, E., Stockton, R., Kiosses, W. B., Kinbara, K.,
Tkachenko, E., Gutierrez, E., Groisman, A., Nguyen, P., Chien, S. et al.
(2008). Localized alpha4 integrin phosphorylation directs shear stress-induced
endothelial cell alignment. Circ. Res. 103, 177-185.
Grossman, S. R., Johannsen, E., Tong, X., Yalamanchili, R. and Kieff, E. (1994).
The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response
elements by the J kappa recombination signal binding protein. Proc. Natl. Acad.
Sci. USA 91, 7568-7572.
Hayashi, H. and Kume, T. (2008). Foxc transcription factors directly regulate Dll4
and Hey2 expression by interacting with the VEGF-Notch signaling pathways in
endothelial cells. PLoS ONE 3, e2401.
Hellström, M., Phng, L.-K., Hofmann, J. J., Wallgard, E., Coultas, L., Lindblom,
P., Alva, J., Nilsson, A.-K., Karlsson, L., Gaiano, N. et al. (2007). Dll4 signalling
through Notch1 regulates formation of tip cells during angiogenesis. Nature 445,
776-780.
Henkel, T., Ling, P. D., Hayward, S. D. and Peterson, M. G. (1994). Mediation of
Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein
J kappa. Science 265, 92-95.
Hogan, B. M., Bos, F. L., Bussmann, J., Witte, M., Chi, N. C., Duckers, H. J. and
Schulte-Merker, S. (2009). Ccbe1 is required for embryonic lymphangiogenesis
and venous sprouting. Nat. Genet. 41, 396-398.
Jakobsson, L., Franco, C. A., Bentley, K., Collins, R. T., Ponsioen, B., Aspalter,
I. M., Rosewell, I., Busse, M., Thurston, G., Medvinsky, A. et al. (2010).
Endothelial cells dynamically compete for the tip cell position during angiogenic
sprouting. Nat. Cell Biol. 12, 943-953.
Jin, H., Garmy-Susini, B., Avraamides, C. J., Stoletov, K., Klemke, R. L. and
Varner, J. A. (2010). A PKA-Csk-pp60Src signaling pathway regulates the switch
between endothelial cell invasion and cell-cell adhesion during vascular
sprouting. Blood 116, 5773-5783.
Kisanuki, Y. Y., Hammer, R. E., Miyazaki, J.-I., Williams, S. C., Richardson, J. A.
and Yanagisawa, M. (2001). Tie2-Cre transgenic mice: a new model for
endothelial cell-lineage analysis in vivo. Dev. Biol. 230, 230-242.
Klein, R. S., Rubin, J. B., Gibson, H. D., DeHaan, E. N., Alvarez-Hernandez, X.,
Segal, R. A. and Luster, A. D. (2001). SDF-1α induces chemotaxis and
enhances Sonic hedgehog-induced proliferation of cerebellar granule cells.
Development 128, 1971-1981.
Kumon, A., Yamamura, H. and Nishizuka, Y. (1970). Mode of action of adenosine
3′,5′-Cyclic phosphate on protein kinase from rat liver. Biochem. Biophys. Res.
Commun. 41, 1290-1297.
Larabee, J. L., Shakir, S. M., Barua, S. and Ballard, J. D. (2013). Increased cAMP
in monocytes augments Notch signaling mechanisms by elevating RBP-J and
transducin-like enhancer of split (TLE). J. Biol. Chem. 288, 21526-21536.
Larrivée, B., Prahst, C., Gordon, E., del Toro, R., Mathivet, T., Duarte, A.,
Simons, M. and Eichmann, A. (2012). ALK1 signaling inhibits angiogenesis by
cooperating with the Notch pathway. Dev. Cell 22, 489-500.
Lawson, N. D. and Weinstein, B. M. (2002). In vivo imaging of embryonic vascular
development using transgenic zebrafish. Dev. Biol. 248, 307-318.
Lu, Y., Xiong, Y., Huo, Y., Han, J., Yang, X., Zhang, R., Zhu, D.-S., Klein-
Hessling, S., Li, J., Zhang, X. et al. (2011). Grb-2-associated binder 1 (Gab1)
regulates postnatal ischemic and VEGF-induced angiogenesis through the
protein kinase A-endothelial NOS pathway. Proc. Natl. Acad. Sci. USA 108,
2957-2962.
Murray, A. J. (2008). Pharmacological PKA inhibition: all may not be what it seems.
Sci. Signal. 1, re4-re4.
Muzumdar, M. D., Tasic, B., Miyamichi, K., Li, L. and Luo, L. (2007). A global
double-fluorescent Cre reporter mouse. Genesis 45, 593-605.
Nakayama, M., Nakayama, A., van Lessen, M., Yamamoto, H., Hoffmann, S.,
Drexler, H. C. A., Itoh, N., Hirose, T., Breier, G., Vestweber, D. et al. (2013).
Spatial regulation of VEGF receptor endocytosis in angiogenesis. Nat. Cell Biol.
15, 249-260.
Pitulescu, M. E., Schmidt, I., Benedito, R. and Adams, R. H. (2010). Inducible
gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in
mice. Nat. Protoc. 5, 1518-1534.
Potente, M., Gerhardt, H. and Carmeliet, P. (2011). Basic and therapeutic aspects
of angiogenesis. Cell 146, 873-887.
Rocha, S. F., Schiller, M., Jing, D., Li, H., Butz, S., Vestweber, D., Biljes, D.,
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